Results 91 to 100 of about 10,242 (124)

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients. [PDF]

Front Immunol
Heitmann JS, Jung S, Wacker M, Maringer Y, Nelde A, Bauer J, Denk M, Hoenisch-Gravel N, Richter M, Oezbek MT, Dubbelaar ML, Bilich T, Pumptow M, Martus P, Illerhaus G, Denzlinger C, Steinbach F, Aulitzky WE, Müller MR, Dörfel D, Rammensee HG, Salih HR, Walz JS.   +22 more
europepmc   +1 more source

Stochastic portfolio optimization: A regret-based approach on volatility risk measures: An empirical evidence from The New York stock market. [PDF]

PLoS One
Larni-Fooeik A, Sadjadi SJ, Mohammadi E.
europepmc   +1 more source

Mitochondria-targeted antioxidant MitoQ radiosensitizes tumors by decreasing mitochondrial oxygen consumption. [PDF]

Cell Death Discov
Rondeau JD, Lipari S, Mathieu B, Beckers C, Van de Velde JA, Mignion L, Da Silva Morais M, Kreuzer M, Colauzzi I, Capeloa T, Pruschy M, Gallez B, Sonveaux P.   +12 more
europepmc   +1 more source

Generative Artificial Intelligence in the Metaverse Era: A Review on Models and Applications. [PDF]

Research (Wash D C)
Zhou H, Chen X, Li J, Zhang Z, Fu Y, Liva MP, Greenbaum D, Hui P.   +7 more
europepmc   +1 more source

Tuberculosis diagnosis and treatment under uncertainty. [PDF]

Proc Natl Acad Sci U S A, 2019
Cassidy R, Manski CF.
europepmc   +1 more source

AteMeVs: An R package for the estimation of the average treatment effect with measurement error and variable selection for confounders. [PDF]

PLoS One
Chen LP, Yi GY.
europepmc   +1 more source